To confirm the safety and efficacy of NEUROASPIS PLP10® in the treatment of individuals, who have been diagnosed with relapsing remitting multiple sclerosis (MS).

Registry ID

EUCTR2015-003147-19

Source registry

EUCTR

Status

Ongoing

Phase

PHASE3

Sponsor

PALUPA Medical Ltd

Start date

2016-07-18

Last update

2026-08-16

Conditions

• Relapsing-Remitting Multiple Sclerosis (RRMS)

Summary

To confirm the safety and efficacy of NEUROASPIS PLP10® in the treatment of individuals, who have been diagnosed with relapsing remitting multiple sclerosis (MS)

Locations

• , , Greece

Related clinical trials

• A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis

View on source registry